Stephanie Walsh, MD
Dermatology · Birmingham, ALNPI 1972706372
Payments from drug & device makers
Across 226 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$972
- Amgen$167
- Mayne Pharma Commercial LLC$160
- Galderma Laboratories, L.p.$153
- Regeneron Healthcare Solutions, Inc.$147
- plus $891 from 19 others
What the payments were for
- Food & beverage$3,741100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $1,251 |
| Novartis | 60 | $972 |
| Amgen | 10 | $167 |
| Mayne Pharma Commercial LLC | 9 | $160 |
| Galderma Laboratories, L.p. | 8 | $153 |
| Regeneron Healthcare Solutions, Inc. | 7 | $147 |
| Johnson & Johnson | 8 | $142 |
| Sanofi | 5 | $111 |
| Sun Pharmaceutical Industries Inc. | 6 | $90 |
| Lilly USA, LLC | 5 | $82 |
| Almirall LLC | 4 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $55 |
| Lifenet Health | 2 | $48 |
| Bristol Myers Squibb | 3 | $41 |
| Kerecis Limited | 1 | $39 |
| Organogenesis Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $32 |
| LEO Pharma Inc. | 2 | $30 |
| DUSA Pharmaceuticals, Inc. | 1 | $24 |
| Pfizer | 2 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Taro Pharmaceuticals USA, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| Bioventus LLC | 1 | $13 |
How this compares
$3,741 in reported general payments places this provider in the 45th percentile of 168 dermatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 65 | $2,566 |
| Mupirocin | 150 | $1,131 |
| Doxycycline Hyclate | 15 | $151 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Birmingham
- Boni ElewskiBirmingham$5.5M
- James KrellBirmingham$4M
- Tiffany MayoBirmingham$1.4M
- Melanie AppellBirmingham$983K
- Julie HarperBirmingham$920K
- Corey HartmanBirmingham$744K
- Lauren GrahamBirmingham$582K
- Kristy CurlBirmingham$158K
- Rajini MurthyBirmingham$153K
- Sarah Lauren HugheyBirmingham$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.